Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 2
2007 1
2008 3
2010 5
2011 7
2012 5
2013 3
2014 4
2015 7
2016 5
2017 6
2018 10
2019 10
2020 12
2021 10
2022 7
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of myasthenia gravis.
Mantegazza R, Cavalcante P. Mantegazza R, et al. Among authors: cavalcante p. Curr Opin Rheumatol. 2019 Nov;31(6):623-633. doi: 10.1097/BOR.0000000000000647. Curr Opin Rheumatol. 2019. PMID: 31385879 Review.
Myasthenia gravis: from autoantibodies to therapy.
Mantegazza R, Bernasconi P, Cavalcante P. Mantegazza R, et al. Among authors: cavalcante p. Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596. Curr Opin Neurol. 2018. PMID: 30156572 Review.
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence.
Gioia U, Tavella S, Martínez-Orellana P, Cicio G, Colliva A, Ceccon M, Cabrini M, Henriques AC, Fumagalli V, Paldino A, Presot E, Rajasekharan S, Iacomino N, Pisati F, Matti V, Sepe S, Conte MI, Barozzi S, Lavagnino Z, Carletti T, Volpe MC, Cavalcante P, Iannacone M, Rampazzo C, Bussani R, Tripodo C, Zacchigna S, Marcello A, d'Adda di Fagagna F. Gioia U, et al. Among authors: cavalcante p. Nat Cell Biol. 2023 Apr;25(4):550-564. doi: 10.1038/s41556-023-01096-x. Epub 2023 Mar 9. Nat Cell Biol. 2023. PMID: 36894671 Free PMC article.
Complement Inhibition for the Treatment of Myasthenia Gravis.
Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P. Mantegazza R, et al. Among authors: cavalcante p. Immunotargets Ther. 2020 Dec 15;9:317-331. doi: 10.2147/ITT.S261414. eCollection 2020. Immunotargets Ther. 2020. PMID: 33365280 Free PMC article. Review.
Autoimmune mechanisms in myasthenia gravis.
Cavalcante P, Bernasconi P, Mantegazza R. Cavalcante P, et al. Curr Opin Neurol. 2012 Oct;25(5):621-9. doi: 10.1097/WCO.0b013e328357a829. Curr Opin Neurol. 2012. PMID: 22941261 Review.
Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab.
Damato V, Spagni G, Monte G, Scandiffio L, Cavalcante P, Zampetti N, Fossati M, Falso S, Mantegazza R, Battaglia A, Fattorossi A, Evoli A. Damato V, et al. Among authors: cavalcante p. Neuromuscul Disord. 2023 Mar;33(3):288-294. doi: 10.1016/j.nmd.2023.02.005. Epub 2023 Feb 11. Neuromuscul Disord. 2023. PMID: 36842303 Free PMC article.
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization.
Iacomino N, Scandiffio L, Conforti F, Salvi E, Tarasco MC, Bortone F, Marcuzzo S, Simoncini O, Andreetta F, Pistillo D, Voulaz E, Alloisio M, Antozzi C, Mantegazza R, De Pas TM, Cavalcante P. Iacomino N, et al. Among authors: cavalcante p. Biomedicines. 2023 Feb 28;11(3):732. doi: 10.3390/biomedicines11030732. Biomedicines. 2023. PMID: 36979710 Free PMC article.
100 results